Fund Research for Principal SmallCap Growth R5 (PTARX)

  • Fund Overview

    Fund Inception Date: Dec 06, 2000
    Category: Small Growth
    Overall Risk: Above Average
    Fund Family: Principal Funds
    Return Since Inception: -2.17%
    YTD Return: 20.42%
    Yield (TTM): 0.00%
    Net Assets: 1.52 M
    Morningstar Rating:
    2 of 5

    The investment seeks long-term growth of capital. The fund primarily invests in common stocks of small-capitalization companies. It normally invests at least 80% of assets in companies with market capitalizations similar to those of companies in the Russell 2000 Growth index. The equity investment philosophy of PGI, the Sub-advisor, is based on the belief that superior stock selection and disciplined risk management provide consistent out-performance. It may invest up to 25% of assets in foreign securities.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player
    Size
    Average Market Cap $923 M
    Market Capitalization Portfolio
    Giant 0.00%
    Large 0.00%
    Medium 15.23%
    Small 65.50%
    Micro 19.27%
    Morningstar Rating as of 10/31/2009
    YTD Returns as of 11/27/2009    		 Style Box Detail calculations do not include the fund's short positions (if any)

  • Fund Performance

    10 year Growth Chart
    Growth of $10,000 from 12/31/2000 to 10/31/2009
    Mouseover the chart to see values for each month.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player

    Total Annualized Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Fund 20.42% 27.29% -8.93% -2.26% — -2.17%
    +/- Category -5.41% -5.63% -2.16% -1.87% — —
    +/- S&P 500 TR -3.17% 1.18% -3.46% -2.74% -0.95% —

    Standardized Annual Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Month (as of 10/31/2009) 16.18% 7.30% -9.88% -1.55% — -2.17%
    Quarter (as of 09/30/2009) 22.93% -13.43% -6.17% 0.26% — -1.56%
    Fund and Category YTD, 1yr, 3yr and 5yr Returns as of 11/27/2009
    Index YTD,1yr, 3ys and 5yr Returns as of 11/27/2009 10 yr and Since Inception Returns as of 10/31/2009
    Inception Date: 12/06/2000
    Ratings are based on risk-adjusted performance.
    View Total Returns

  • Fund Portfolio Profile

    Sector Breakdown

    Stocks
    Information 29.30%
    Service 44.21%
    Manufacturing 23.63%

    Asset Allocation

    Short Long Net Assets
    Cash 0.48% 2.85% 2.38%
    Stocks 0.00% 97.62% 97.62%
    Bonds 0.00% 0.00% 0.00%
    Other 0.00% 0.00% 0.00%
    Foreign Stocks
    (as a % of assets)    		 0.00% 2.43% 2.43%
    Data as of 10/31/2009 Data as of 10/31/2009 View Fund Portfolio

    Top 10 Holdings

    Sector P/E Return as of 10/31/2009 Net Assets
    = HUMAN GENOME SCIENCES INC (HGSI) Healthcare — 1,224.06% 1.91%
    + WARNACO GROUP INC (WRC) Consumer Goods 25.52 118.29% 1.14%
    = BERRY PETE CO (BRY) Energy 25.75 261.84% 1.11%
    * NEWMARKET CORP (NEU) Industrial Materials 12.16 191.98% 1.08%
    = OREXIGEN THERAPEUTICS INC (OREX) Healthcare — 25.81% 1.01%
    = SOLERA HOLDINGS INC (SLH) Software 38.18 34.04% 0.99%
    * HAEMONETICS CORP (HAE) Healthcare 21.38 -3.58% 0.96%
    = INCYTE CORP (INCY) Healthcare — 76.78% 0.94%
    = TUPPERWARE BRANDS CORP (TUP) Consumer Goods 18.94 100.22% 0.92%
    + CHATTEM INC (CHTT) Consumer Goods 15.28 -10.47% 0.92%
    + Increase - Decrease = No change * New since last portfolio
    Top 10 holdings account for the fund's short positions (if any). Net short positions appear shaded.
    P/E as of 11/27/2009
    All other data as of 09/30/2009
    View Fund Portfolio

  • Sales Information

    Sales Charge %

    Initial —
    Deferred —
    Taken from prospectus dated 03/01/2009
    Expense Ratio (based on net assets) 1.03%
    Taken from annual report dated 10/31/2008

  • Fund Management